Avior Wealth Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100
Closed -$810 1571
2023
Q1
$810 Sell
100
-100
-50% -$803 ﹤0.01% 1477
2022
Q4
$1.26K Sell
200
-400
-67% -$2.79K ﹤0.01% 1097
2022
Q3
$4K Buy
600
+260
+76% +$1.81K ﹤0.01% 949
2022
Q2
$2K Buy
340
+30
+10% +$419 ﹤0.01% 933
2022
Q1
$7K Buy
+310
New +$7.58K ﹤0.01% 868
2020
Q1
Sell
-200
Closed -$5K 773
2019
Q4
$5K Hold
200
﹤0.01% 651
2019
Q3
$4K Hold
200
﹤0.01% 630
2019
Q2
$5K Hold
200
﹤0.01% 642
2019
Q1
$4K Hold
200
﹤0.01% 581
2018
Q4
$3K Hold
200
﹤0.01% 645
2018
Q3
$5K Hold
200
﹤0.01% 627
2018
Q2
$5K Buy
+200
New +$4.14K ﹤0.01% 643

Other funds holding BHC

Avior Wealth Management's BHC Position: Q2 2023 in Review

Avior Wealth Management sold out of Bausch Health (BHC) in Q2 2023, closing a stake of 100 shares — an estimated $810 sold.

Avior Wealth Management first reported a position in BHC in Q2 2018 and held it in 12 quarters. The position peaked at $7K in Q1 2022. 232 funds tracked by Wall St. Rank hold BHC as of Q2 2023.

  • Avior Wealth Management reported no remaining Bausch Health position as of Q2 2023 after selling out during the quarter.
  • Avior Wealth Management sold 100 Bausch Health shares in Q2 2023, an estimated $810.
  • Avior Wealth Management first reported a position in Bausch Health in Q2 2018 and held it in 12 quarters.
  • Avior Wealth Management's Bausch Health position peaked at $7K in Q1 2022.
  • 232 funds tracked by Wall St. Rank held Bausch Health as of Q2 2023.

Based on Avior Wealth Management's 13F filing for Q2 2023, filed 19 Jul 2023.